AcquisitionOther
Halozyme Therapeutics, Inc. acquired Elektrofi, Inc.
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Halozyme Therapeutics, Inc. -> Elektrofi, Inc. · $750 million upfront plus up to $150 million in milestone payments
Open source record (SEC) ↗